{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:49:34Z","timestamp":1777949374474,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Diagnosis and Treatment Innovation Research Project of Shanghai Pudong Hospital","award":["YJLC202409"],"award-info":[{"award-number":["YJLC202409"]}]},{"name":"Plan of Artificial Intelligence-Driven Reform of Scientific Research Paradigms and Empowerment of Discipline Advancement","award":["Z-2024-369-036"],"award-info":[{"award-number":["Z-2024-369-036"]}]},{"name":"Health Science and Technology of Shanghai Municipal Commission of Health Committee","award":["20214Y0268"],"award-info":[{"award-number":["20214Y0268"]}]},{"name":"the Health Commission of Pudong New Area Health and Technology Project","award":["PW2023A-31"],"award-info":[{"award-number":["PW2023A-31"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44958-8","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:36:33Z","timestamp":1773858993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Piperacillin\/tazobactam plus erythromycin improves clinical outcomes in AECOPD with bacterial lower respiratory tract infections: a retrospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Yemeng","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenfen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"44958_CR1","unstructured":"Global initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report. https:\/\/goldcopd.org\/wp-content\/uploads\/2024\/11\/GOLD-2025-Report-v1.0-15Nov2024_WMV.pdf."},{"key":"44958_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11739-020-02420-1","volume":"16","author":"E Crisafulli","year":"2021","unstructured":"Crisafulli, E. et al. Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD. Intern. Emerg. Med. 16, 401\u2013408. https:\/\/doi.org\/10.1007\/s11739-020-02420-1 (2021).","journal-title":"Intern. Emerg. Med."},{"key":"44958_CR3","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.2147\/copd.S433183","volume":"18","author":"Y Qian","year":"2023","unstructured":"Qian, Y., Cai, C., Sun, M., Lv, D. & Zhao, Y. Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review. Int. J. Chronic Obstr. Pulm. Dis. 18, 2707\u20132723. https:\/\/doi.org\/10.2147\/copd.S433183 (2023).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"44958_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/15412555.2021.1979500","volume":"18","author":"PL Nguyen","year":"2021","unstructured":"Nguyen, P. L. et al. Trends in Incidence, and Mortality of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the United States Emergency Department (2010\u20132018). Copd 18, 567\u2013575. https:\/\/doi.org\/10.1080\/15412555.2021.1979500 (2021).","journal-title":"Copd"},{"key":"44958_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s15010-019-01350-1","volume":"48","author":"M Moghoofei","year":"2020","unstructured":"Moghoofei, M., Azimzadeh Jamalkandi, S., Moein, M., Salimian, J. & Ahmadi, A. Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Infection 48, 19\u201335. https:\/\/doi.org\/10.1007\/s15010-019-01350-1 (2020).","journal-title":"Infection"},{"key":"44958_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.arbres.2021.05.011","volume":"58","author":"JJ Soler-Catalu\u00f1a","year":"2022","unstructured":"Soler-Catalu\u00f1a, J. J. et al. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome. Arch. Bronconeumol. 58, 159\u2013170. https:\/\/doi.org\/10.1016\/j.arbres.2021.05.011 (2022).","journal-title":"Arch. Bronconeumol."},{"key":"44958_CR7","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMra0800353","volume":"359","author":"S Sethi","year":"2008","unstructured":"Sethi, S. & Murphy, T. F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355\u20132365. https:\/\/doi.org\/10.1056\/NEJMra0800353 (2008).","journal-title":"N. Engl. J. Med."},{"key":"44958_CR8","doi-asserted-by":"publisher","unstructured":"Wedzicha, J. A. E. C. C. et al. Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline. Eur. Respir. J. 49. https:\/\/doi.org\/10.1183\/13993003.00791-2016 (2017).","DOI":"10.1183\/13993003.00791-2016"},{"key":"44958_CR9","doi-asserted-by":"publisher","first-page":"e23571","DOI":"10.2196\/23571","volume":"23","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller, L. et al. A Risk-Based Clinical Decision Support System for Patient-Specific Antimicrobial Therapy (iBiogram): Design and Retrospective Analysis. J. Med. Internet. Res. 23, e23571. https:\/\/doi.org\/10.2196\/23571 (2021).","journal-title":"J. Med. Internet. Res."},{"key":"44958_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2478\/jtim-2018-0006","volume":"6","author":"YG Zhu","year":"2018","unstructured":"Zhu, Y. G., Tang, X. D., Lu, Y. T., Zhang, J. & Qu, J. M. Contemporary Situation of Community-acquired Pneumonia in China: A Systematic Review. J. translational Intern. Med. 6, 26\u201331. https:\/\/doi.org\/10.2478\/jtim-2018-0006 (2018).","journal-title":"J. translational Intern. Med."},{"key":"44958_CR11","doi-asserted-by":"publisher","unstructured":"Martin-Loeches, I. et al. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Eur. Respir. J. 61. https:\/\/doi.org\/10.1183\/13993003.00735-2022 (2023).","DOI":"10.1183\/13993003.00735-2022"},{"key":"44958_CR12","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay, J. P. et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am. J. Respir. Crit Care Med. 200, e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST (2019).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"44958_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/s2213-2600(23)00412-5","volume":"12","author":"EJ Giamarellos-Bourboulis","year":"2024","unstructured":"Giamarellos-Bourboulis, E. J. et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respiratory Med. 12, 294\u2013304. https:\/\/doi.org\/10.1016\/s2213-2600(23)00412-5 (2024).","journal-title":"Lancet Respiratory Med."},{"key":"44958_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ckj\/sfab158","volume":"15","author":"NC Chesnaye","year":"2022","unstructured":"Chesnaye, N. C. et al. An introduction to inverse probability of treatment weighting in observational research. Clin. kidney J. 15, 14\u201320. https:\/\/doi.org\/10.1093\/ckj\/sfab158 (2022).","journal-title":"Clin. kidney J."},{"key":"44958_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3760\/cma.j.cn112147-20210109-00031","volume":"44","author":"(CTS)","year":"2013","unstructured":"(CTS). CMDA)., C. M. D. A. Guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease (2021 revision). Chin. J. Tuberc Respir Dis. 44, 170\u2013205. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20210109-00031 (2013).","journal-title":"Chin. J. Tuberc Respir Dis."},{"key":"44958_CR16","doi-asserted-by":"publisher","unstructured":"Agust\u00ed, A. et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur. Respir. J. 61. https:\/\/doi.org\/10.1183\/13993003.00239-2023 (2023).","DOI":"10.1183\/13993003.00239-2023"},{"key":"44958_CR17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1513\/AnnalsATS.202204-319OC","volume":"20","author":"R Spies","year":"2023","unstructured":"Spies, R. et al. Sputum Color as a Marker for Bacteria in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Annals Am. Thorac. Soc. 20, 738\u2013748. https:\/\/doi.org\/10.1513\/AnnalsATS.202204-319OC (2023).","journal-title":"Annals Am. Thorac. Soc."},{"key":"44958_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa1800201","volume":"380","author":"R Stets","year":"2019","unstructured":"Stets, R. et al. Omadacycline for Community-Acquired Bacterial Pneumonia. N. Engl. J. Med. 380, 517\u2013527. https:\/\/doi.org\/10.1056\/NEJMoa1800201 (2019).","journal-title":"N. Engl. J. Med."},{"key":"44958_CR19","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s00134-022-06811-0","volume":"48","author":"TA Miano","year":"2022","unstructured":"Miano, T. A. et al. Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study. Intensive Care Med. 48, 1144\u20131155. https:\/\/doi.org\/10.1007\/s00134-022-06811-0 (2022).","journal-title":"Intensive Care Med."},{"key":"44958_CR20","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ajic.2015.05.020","volume":"43","author":"TC Havey","year":"2015","unstructured":"Havey, T. C., Hull, M. W., Romney, M. G. & Leung, V. Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: Opportunities for antimicrobial stewardship. Am. J. Infect. Control. 43, 946\u2013950. https:\/\/doi.org\/10.1016\/j.ajic.2015.05.020 (2015).","journal-title":"Am. J. Infect. Control"},{"key":"44958_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/FI-2010-288","volume":"101","author":"MB Kursa","year":"2010","unstructured":"Kursa, M. B., Jankowski, A. & Rudnicki, W. R. Boruta\u2013a system for feature selection. Fundamenta Informaticae. 101, 271\u2013285. https:\/\/doi.org\/10.3233\/FI-2010-288 (2010).","journal-title":"Fundamenta Informaticae"},{"key":"44958_CR22","doi-asserted-by":"publisher","first-page":"106584","DOI":"10.1016\/j.cmpb.2021.106584","volume":"214","author":"Y Nohara","year":"2022","unstructured":"Nohara, Y., Matsumoto, K., Soejima, H. & Nakashima, N. Explanation of machine learning models using shapley additive explanation and application for real data in hospital. Comput. Methods Programs Biomed. 214, 106584. https:\/\/doi.org\/10.1016\/j.cmpb.2021.106584 (2022).","journal-title":"Comput. Methods Programs Biomed."},{"key":"44958_CR23","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1007\/s11606-022-07486-5","volume":"37","author":"N Baalbaki","year":"2022","unstructured":"Baalbaki, N., Giuliano, C., Hartner, C. L., Kale-Pradhan, P. & Johnson, L. Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD. J. Gen. Intern. Med. 37, 4183\u20134188. https:\/\/doi.org\/10.1007\/s11606-022-07486-5 (2022).","journal-title":"J. Gen. Intern. Med."},{"key":"44958_CR24","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.pupt.2021.102095","volume":"71","author":"J Pollock","year":"2021","unstructured":"Pollock, J. & Chalmers, J. D. The immunomodulatory effects of macrolide antibiotics in respiratory disease. Pulm. Pharmacol. Ther. 71, 102095. https:\/\/doi.org\/10.1016\/j.pupt.2021.102095 (2021).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"44958_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000321374","volume":"80","author":"ZY He","year":"2010","unstructured":"He, Z. Y. et al. Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease. Respir. Int. Rev. Thorac. Dis. 80, 445\u2013452. https:\/\/doi.org\/10.1159\/000321374 (2010).","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"44958_CR26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","volume":"178","author":"TA Seemungal","year":"2008","unstructured":"Seemungal, T. A. et al. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am. J. Respir. Crit Care Med. 178, 1139\u20131147. https:\/\/doi.org\/10.1164\/rccm.200801-145OC (2008).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"44958_CR27","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1378\/chest.120.3.730","volume":"120","author":"T Suzuki","year":"2001","unstructured":"Suzuki, T. et al. Erythromycin and common cold in COPD. Chest 120, 730\u2013733. https:\/\/doi.org\/10.1378\/chest.120.3.730 (2001).","journal-title":"Chest"},{"key":"44958_CR28","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2147\/copd.S373595","volume":"17","author":"T Morasert","year":"2022","unstructured":"Morasert, T., Kriengwattanakul, O. & Kulalert, P. Effect of Macrolide Antibiotics on In-Hospital Mortality Among Acute Exacerbation of COPD Patients: A Propensity Score-Matched Analysis. Int. J. Chronic Obstr. Pulm. Dis. 17, 2229\u20132239. https:\/\/doi.org\/10.2147\/copd.S373595 (2022).","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"44958_CR29","doi-asserted-by":"publisher","first-page":"E576","DOI":"10.9778\/cmajo.20200157","volume":"9","author":"M Yan","year":"2021","unstructured":"Yan, M. et al. Long-term macrolide therapy for chronic obstructive pulmonary disease: a population-based time series analysis. CMAJ open. 9, E576\u2013e584. https:\/\/doi.org\/10.9778\/cmajo.20200157 (2021).","journal-title":"CMAJ open."},{"key":"44958_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jac\/dki093","volume":"55","author":"PM Filius","year":"2005","unstructured":"Filius, P. M. et al. An additional measure for quantifying antibiotic use in hospitals. J. Antimicrob. Chemother. 55, 805\u2013808. https:\/\/doi.org\/10.1093\/jac\/dki093 (2005).","journal-title":"J. Antimicrob. Chemother."},{"issue":"Suppl 3","key":"44958_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/bf01745246","volume":"20","author":"F S\u00f6rgel","year":"1994","unstructured":"S\u00f6rgel, F. & Kinzig, M. Pharmacokinetic characteristics of piperacillin\/tazobactam. Intensive Care Med. 20 (Suppl 3), 14\u201320. https:\/\/doi.org\/10.1007\/bf01745246 (1994).","journal-title":"Intensive Care Med."},{"key":"44958_CR32","doi-asserted-by":"publisher","unstructured":"Wolpert, D. H. Stacked generalization. Neural Netw.. 5, 241\u2013259. (1992). https:\/\/doi.org\/10.1016\/S0893-6080(05)80023-1","DOI":"10.1016\/S0893-6080(05)80023-1"},{"key":"44958_CR33","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1002\/widm.1249","volume":"8","author":"O Sagi","year":"2018","unstructured":"Sagi, O. & &Rokach, L. Ensemble learning: A survey. Wiley interdisciplinary reviews: data Min. Knowl. discovery. 8, e1249. https:\/\/doi.org\/10.1002\/widm.1249 (2018).","journal-title":"Wiley interdisciplinary reviews: data Min. Knowl. discovery"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44958-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44958-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44958-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:21:01Z","timestamp":1777850461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44958-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44958"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44958-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This investigation was designed as a retrospective analysis based on previously collected clinical data and was conducted under a waiver of informed consent. The waiver was formally reviewed and approved by the Ethics Committee of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, prior to the initiation of the study. Furthermore, the study protocol, developed in strict compliance with the ethical principles outlined in the Declaration of Helsinki and its subsequent revisions, received approval from the same committee (Approval No: 2024-KY-001-E01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"14102"}}